Caption Management, LLC - DICERNA PHARMACEUTICALS INC ownership

DICERNA PHARMACEUTICALS INC's ticker is DRNA and the CUSIP is 253031108. A total of 178 filers reported holding DICERNA PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.31 and the average weighting 0.2%.

Quarter-by-quarter ownership
Caption Management, LLC ownership history of DICERNA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2021$2,569,000
+14.8%
127,443
+112.4%
0.03%
-3.3%
Q2 2021$2,238,000
+45.9%
60,0000.0%0.03%
-6.2%
Q1 2021$1,534,000
+16.0%
60,0000.0%0.03%
+6.7%
Q4 2020$1,322,000
+206.0%
60,000
+150.0%
0.03%
+200.0%
Q3 2020$432,000
-15.0%
24,000
+20.0%
0.01%
-37.5%
Q2 2020$508,00020,0000.02%
Other shareholders
DICERNA PHARMACEUTICALS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 1,355,392$29,859,0006.21%
Bain Capital Life Sciences Investors, LLC 3,080,237$67,858,0004.26%
DAFNA Capital Management LLC 587,756$12,948,0003.85%
SILVERARC CAPITAL MANAGEMENT, LLC 227,388$5,009,0002.91%
RTW INVESTMENTS, LP 7,253,857$159,802,0002.68%
Parkman Healthcare Partners LLC 331,513$7,303,0001.87%
Evolutionary Tree Capital Management, LLC 60,864$1,341,0001.02%
Eagle Health Investments LP 69,000$1,520,0000.97%
Woodline Partners LP 1,358,796$29,934,0000.79%
Affinity Asset Advisors, LLC 40,000$881,0000.47%
View complete list of DICERNA PHARMACEUTICALS INC shareholders